Bill Cassidy
The Public Record
Bill Morgan Cassidy is an American politician and physician currently serving as the junior United States Senator from Louisiana, a position he has held since January 6, 2015. A member of the Republican Party, Cassidy has focused on various issues during his tenure, including healthcare, veterans' affairs, and economic development. He has been an advocate for reforms in the healthcare system and has expressed strong opinions on public health policies, including vaccination schedules.
I hope you will continue to fight for what is truly best for our families, by supporting and co-sponsoring the FAMILY Act (S. 337).
I think my final assessment is that it is those lower-income people who do not have the benefit now, that we have limited capacity to raise payroll taxes if we are to make current obligations.
I am very sympathetic to what these small business owners said, which is, I have a small business, and I have thin margins, and I have three employees.
I am very concerned about our ability to pay our current obligations and wonder again if we just are not supplanting with Federal tax dollars for some folks--not for all, because some do not have the benefit.
There is a limit to how much we can raise that payroll tax without adversely affecting employment.
I will say, frankly, my concern is, if these folks who already are getting it now have business subtracting that which they pay and putting the financial burden on the taxpayer, the taxpayer is a little bit worse off.
So if you will, the Federal program would supplant that which business is already doing, which would increase the cost to the Federal taxpayer?
A 2017 Pew poll shows overwhelming majorities of Americans support paid sick leave and paid maternity leave.
Well, I'm speaking of, say, doxycycline, a pill which I'm told now costs $13.50. It's out there for 50 years. It should cost 50 cents.
What if we extend that to if both agencies have a secure supply chain, that a wholesaler could go to Great Britain and buy a generic drug.
The Martin Shkrelis of the world, who get a single drug and then they raise the price dramatically.
Let me stop--my office has just recently posted a bill, a white paper on how to lower costs.
I agree totally with Senator Bennet. He and I and others are working on a price transparency initiative.
The fact that he died obviously indicates that this was not an effective strategy.
If we are having turnover, and if we are in a health care system and some of that turnover is negatively impacting patients, that is negative for the patient and negative for the taxpayer.
I appreciate your service, and I look forward to working with you on this issue.